CD274 and neoplasm: Consistent with these functions, immunotherapy, including the anti-tumor effects of CTLA-4 and programmed death-ligand 1/programmed death-1 (PD-L1/PD-1) blockade, have become leading and powerful treatments for LUAD treatment [15–17].